Novartis AG (NOVNz)

BATS Europe
Currency in CHF
Disclaimer
94.110
-0.945(-1.00%)
Closed
NOVNz Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
94.01096.275
52 wk Range
83.015100.950
Bid/Ask
94.20 / 94.20
Prev. Close
95.055
Open
95.29
Day's Range
94.01-96.275
52 wk Range
83.015-100.95
Volume
252,289
Average Volume (3m)
212,781
1-Year Change
3.11%
Fair Value
Unlock
Fair Value Upside
Unlock
NOVNz Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
114.260
Upside
+21.295%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 28 consecutive years

Compare NOVNz to Peers and Sector

Metrics to compare
NOVNz
Peers
Sector
Relationship
P/E Ratio
21.3x17.1x−0.6x
PEG Ratio
0.180.710.00
Price/Book
5.1x3.4x2.6x
Price / LTM Sales
4.4x2.9x3.1x
Upside (Analyst Target)
-−3.6%57.7%
Fair Value Upside
Unlock13.1%8.9%Unlock

People Also Watch

93.78
NESN
-0.49%
829.50
ASML
-1.07%
472.50
ZURN
-1.38%
48.31
ABBN
+0.02%

Novartis AG Company Profile

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Employees
76057
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.